Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac and Dexamethasone for PCME Prevention in NPDR
NCT04940338Phase 4Completed
- Sponsor
- Clinical Hospital Center Zagreb
- Start
- May 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of bromfenac sodium, dexamethasone iontophoretic patch in pseudophakic cystoid macular edema (PCME), sponsored by Clinical Hospital Center Zagreb. Started May 2021; status: completed.
02
Drugs
bromfenac sodiumdexamethasone iontophoretic patch
03
Conditions
pseudophakic cystoid macular edema (PCME)
Beyond the preview
Go deeper on NCT04940338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940338.